News Centre

Boehringer Ingelheim News Centre

See the latest Boehringer Ingelheim news releases. To quickly find all news releases on a specific topic, please use the fulltext search.

back 1 2 3 4 5 6 7 8 910next

08.06.2009	New data from Boehringer Ingelheim's ongoing linagliptin trial programme show promising safety and efficacy results
29.05.2009	Boehringer Ingelheim and DxS sign an agreement for a companion diagnostic to identify EGFR mutations in patients with lung cancer
21.04.2009	Boehringer Ingelheim maintains its growth path in 2008, again growing faster than the pharmaceutical market - major investments once again in Research and Development
20.03.2009	Boehringer Ingelheim´s novel oral anticoagulant dabigatran etexilate is the frontrunner for stroke prevention in atrial fibrillation: final patient completes treatment in the RE-LY ^® study, the largest
31.10.2008	Largest study of its kind reveals low sexual desire is most common female sexual problem
22.10.2008	Boehringer Ingelheim broadens oncology pipeline with promising new data for potentially first in class Plk1 inhibitor
17.10.2008	From Curiosity to Discovery: Boehringer Ingelheim's pipeline update unveils novel investigational compounds heralding the Company's entry into Type 2 Diabetes
23.09.2008	Established Safety Profile of SPIRIVA ^® reinforced by analysis from 30 Rigorously Controlled Clinical Trials
31.08.2008	Canadian-led landmark trial shows MICARDIS ^® reduces the risk of cardiovascular death, heart attack and stroke in high-risk ACE-intolerant patients
18.06.2008	MICARDIS ^®-based regimens help more patients achieve their blood pressure goals

back 1 2 3 4 5 6 7 8 910next

Visit our corporate website for more information on Boehringer Ingelheim.

RSS feeds allow you to receive latest news and information about Boehringer Ingelheim.